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Control of hyperglycemia is an important treatment in metabolic disorders such as type II diabetes and 
obesity. α-Amylase, as the first enzyme of glucose release from dietary polysaccharides, is a potential 
target to identify new sources of novel anti-obesity and anti-diabetic drugs. In this work, different herbal 
extracts as α-amylase inhibitors were studied by measuring the rate of the cleavage of a maltooligomer 
substrate 2-chloro-4-nitrophenyl-β-D-maltoheptoside. Measurement of chromophore containing products 
after reversed phase HPLC separation was used for α-amylase activity measurement. Rates of hydrolysis 
catalysed by human salivary α-amylase were determined in the presence and absence of lyophilised water 
extracts of eleven herbs. Remarkable bioactivities were found for extracts of Cinnamomum zeylanicum 
Blume (bark), Camellia sinensis L. (leaf), Ribes nigrum L. (leaf), Laurus nobilis L. (leaf), Vaccinium 
macrocarpon Aiton (fruit) and Syzygium aromaticum L. (bud). Determined IC50 values were in 0.017–41 
μg/ml range for these six selected plant extracts. Our results confirm the applicability of this HPLC-based 
method for the quick and reliable comparison of plants as α-amylase inhibitors.
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INTRODUCTION
Obesity and the related health consequences such as diabetes, metabolic syndrome 
and hypertonia cause major worldwide concern [15]. Regular treatments necessitate 
diet, exercises or full lifestyle modification and have a high failure rate. Currently 
only a few anti-obesity drugs exist however they are not very effective [11]. 
Therefore, enzymes that catalyze digestion of dietary carbohydrates can be potential 
targets for therapeutic interventions. Human α-amylases (1,4-α-D-glucan-4-
glucanohydrolase) are endo enzymes, which catalyse random hydrolysis of starch, the 
main source of glucose in human diet [5]. Human salivary α-amylase (HSA), the first 
enzyme of glucose absorption pathway, initiates the hydrolysis of α-(1,4) glycosidic 
bonds in the dietary starch into smaller oligosaccharides. Further digestion of starch 
and oligosaccharides takes place in the small intestine by human pancreatic α-amylase 
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(HPA) [13] a very closely related isoform of HSA with 97% sequence identity [4]. In 
this work HSA was selected as model enzyme of human α-amylases.
As alternative to the currently used anti-diabetic drug acarbose, which has several 
undesirable side effects, there is an increased need to find natural compounds [18]. 
Several herb extracts were tested recently as potential α-amylase and α-glucosidase 
inhibitor. Cinnamon extracts markedly inhibited pancreatic α-amylase and intestinal 
α-glucosidase enzymes [2]. Gao et al. [7] published, that the C. sinensis extract dis-
played a favorable inhibitory activity on α-amylase. It was reported that blackcurrant 
(Ribes nigrum) had inhibitory activity on α-glucosidase and α-amylase enzymes [16]. 
In addition, a study demonstrated beneficial effects of bay leaves (Laurus nobilis) on 
blood glucose, total cholesterol, LDL cholesterol, HDL cholesterol and triglycerid 
levels in subject with type 2 diabetes [12]. Based on experimental results, it can also 
be concluded, that anti-diabetic effect of bilberry (Vaccinium myrtillus) leaves might 
be due to the inhibition of the α-amylase by the flavonoid quercetin [9]. Other results 
proved, that cranberry (Vaccinicum macrocarpon), containing p-coumaric acid and 
quercetin derivatives as the main phenolic compounds, inhibited α-amylase activity 
[19]. A study of clove (Syzygium aromaticum) presented that strong correlation 
existed between the enzyme inhibitory activites and the phenolic content of the 
extracts [1]. The above-mentioned studies used starch as substrate and mainly reduc-
ing sugar determination after a certain time of incubation by dinitrosalycilic acid 
(DNS) method for α-amylase activity measurement. The verification of the real initial 
rate determination usually was lacking. DNS method has several limitations and 
drawbacks: e.g. requires high volumes of samples, involves several steps and is 
labour-intensive and time-consuming [8].
The substrate, we used in this work, was 2-chloro-4-nitrophenyl-β-D-maltoheptoside 
(CNP-G7) [6]. This synthetic substrate overlaps with the active site of the HSA and 
behaves similar to the natural substrate. Action pattern of HSA revealed, that trimer 
(CNP-G3) is the main component (50%) of the released three reducing end products. 
Chromophore aglycon allows UV detection at 302 nm with appropriate sensitivity. 
The β-glycosidic bond of aglycon is significant, because α-amylase cannot cleave 
that, therefore reducing end products always contain a chromophore group [10]. 
Previous isothermic titration calorimetry (ITC) based assays were strengthened the 
hypothesis that the CNP-G7 mimic the starch, since it has similar Km values like 
natural starch in HSA catalysed enzyme reaction, and IC50 values of acarbose deter-
mined on starch and G7 were also similar [14]. 
In the present work, eleven plants were selected, based on above cited previous 
results, to test as α-amylase inhibitors by measuring the initial rate of the cleavage of 
a maltooligomer substrate, 2-chloro-4-nitrophenyl-β-D-maltoheptoside.
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MATERIALS AND METHODS
Enzyme
Human salivary α-amylase (EC 3.2.1.1, A0521 Sigma, α-Amylase from human saliva 
Type IX-A, lyophilized powder, 1,000–3,000 units/mg protein). The enzyme gave 
a single band using SDS-PAGE and did not show α- or β-glucosidase activity. The 
100 U enzyme was dissolved in 1.0 ml HPLC pure water and diluted tenfold.
Substrate
2-Chloro-4-nitrophenyl-β-D-maltoheptoside (CNP-G7) substrate was synthethised 
using a method described by Farkas et al. [6] and the product was fully characterised 
earlier. The purity and identity of substrate were determined by HPLC and MALDI-
TOF MS (Fig. 1). Measured and calculated m/z values for sodium adduct of CNP-G7 
[C48H74O38NCl + Na]+ were 1330.34 and 1330.3475, respectively. The resolution was 
monoisotopic, and isotopic pattern verified the presence of chlorine in the molecule.
Buffer
MES (2-(N-Morfolino)-etan sulfonic acid, Sigma M8250) 25 mM, was disolved in 
HPLC pure water (Molar Chemicals) and stabilised with CaCl2 ∙ 2 H2O (Sigma) 5.0 
mM. pH was adjusted to 7.0 with NaOH (Molar Chemicals) or HCl (Molar 
Chemicals).
Plant extracts
Plants were purchased from the local herb store. Eleven plants species were examined 
as follows: Laurus nobilis L. (leaf), Sideritis montana L. (leaf), Vaccinium macrocar-
pon Aiton (fruit), Hibiscus sabdariffa L. (flower), Cyclopia genistoides L. Vent. 
(leaf), Rosmarinus officinalis L. (leaf), Syzygium aromaticum L. (bud), Cinnamomum 
zeylanicum Blume (bark), Phaseolus vulgaris L. (pod), Camellia sinensis L. (leaf), 
Ribes nigrum L. (leaf).
All plants were extracted with the same method. Ten g of each dried herbs was 
boiled in 500 ml distilled water at 100 °C for 20 min and the extracts were lyophilized 
using Christ Alpha1-4 freeze-drier for 36 hours. Same amount of the obtained residue 
(5 mg) was solved in HPLC pure water (1 ml) and centrifuged at 10,000 rpm to 
eliminate non-water-soluble particles. Appropriate dilutions were made with buffer 
before inhibition measurements.
130 István takács et al.
Acta Biologica Hungarica 68, 2017
MALDI-TOF mass spectrometry
MALDI-TOF MS analysis of CNP-G7 was performed in positive-ion mode using a 
Bruker Biflex MALDI-TOF mass spectrometer equipped with delayed-ion extraction. 
Desorption/ionisation of the sample molecules was effected with a 337 nm nitrogen 
laser. Spectra from 100 laser shots were summarized using 19 kV accelerating and 20 
kV reflectron voltage. External calibration was applied using the [M + Na]+ peaks of 
cyclodextrins DP 6–8, m/z: 995.3067, m/z: 1157.3595, m/z: 1319.4124 Da, respec-
tively. The spectrum was performed in 2,5-dihydroxy benzoic acid (DHB) matrix.
Fig. 1. Reversed phase HPLC chromatogram (A) and MALDI-TOF mass spectrum (B) of CNP-G7 sub-
strate purified by preparative HPLC. Chromatographic conditions are defined in section 2.6
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HPLC method for α-amylase activity measurement
For the assay, a solution of HSA (100 U/ml) was prepared in MES buffer and 
diluted tenfold. For each measurement 5 mM CNP-G7 substrate was prepared 
freshly in MES buffer. Eight μl enzyme (10 U/ml) and 400 μl substrate was mixed 
with vortex and incubated at 37 °C for 5 minutes. Twenty μl of the solution was 
injected to the loop in every 15 minutes in total of 4 times. The device was an 
Agilent Infiniti 1100 instrument equipped with quaternary pump, degasser and 
manual sample injector. Separation was made using a Genesis C18 (15 cm × 4.6 mm 
120 Å 4 µm) column. MeCN/H2O was used as isocratic eluent (15:85, v/v) with 
flow rate of 0.8 ml/min. The injection loop was 20 μl and the column temperature 
was set to 37 °C. Detection of CNP-G7 and CNP-oligomer products were carried 
out at 302 nm. The amount of CNP-G3 was specified by the area of peak. Linearity 
(0.01–5 mM, s = 8944.76 r = 0.99932), system precision (RSD = 0.88) and resolu-
tion R > 2 (3.0 and 2.36 for tetramer-trimer and trimer-dimer pairs, respectively) 
were determined as system suitability parameters. The reaction rate was determined 
by the representation of the area of CNP-G3 measured in four different times 
(Fig. 2). For the evaluation linear regression was used and the slope of fitted linear 
curve gave the enzyme activity.
Fig. 2. Reaction rate measurement of HSA catalysed CNP-G7 hydrolysis without inhibitor using reversed 
phase HPLC separation of substrate and products. Chromatographic conditions are defined in 2.6, chro-
matograms were recorded in every 15 minutes. Increasing area data of CNP-G3 at 5, 20, 35 and 50 min 
were represented on Fig. 3
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Inhibiton studies
Inhibiton assays were performed using the same method for each plant. Extracts were 
dissolved in HPLC pure water to a concentration of 5 mg/ml as a stock solution. Eight 
μl of appropriate logarithmic dilutions of extracts and 8 μl HSA (10 U/ml) were 
mixed with vortex and incubated for 4 minutes at 37 °C. After incubation the enzyme 
substrate reaction was started with the addition of 400 μl CNP-G7 (5 mM) solution 
and further incubated for 5 minutes. After 5 minutes 20 μl of the solution was inject-
ed in to the column repeatedly in every 15 minutes, in total 4 times. For those plants 
that displayed good inhibition the IC50 values were determined at constant substrate 
and enzyme concentration using different concentration (96–0.0096 µg/ml) of plant 
extracts as inhibitor. For IC50 determination, the residual enzyme activity in the pres-
ence of inhibitor (calculated from the rate values) was plotted as a function of the 
logarithm of inhibitor concentration and the curve was fitted using non-linear regres-
sion.
RESULTS
After the water extraction of each plants the lyophilisation yielded various amount of 
dry product summarised in Table 1.
Enzyme activity was measured on HSA catalysed hydrolysis of CNP-G7 substrate 
in the presence of plant extracts using the same reaction conditions. Kinetic curves 
showed decreasing reaction rates due to the plant extracts of 96 μg/ml concentration 
(Fig. 3). Acarbose caused total inhibition of CNP-G7 hydrolysis under the same con-
Table 1
Yields of water extraction of plant samples
Plant Yield of extraction 
(mg/10 g)
Colour
Name Latin name Part used
Bay Laurus nobilis leaf 1840 light brown
Blackcurrant Ribes nigrum leaf 2400 dark brown
Cinnamon Cinnamomum zeylanicum cortex 3520 brown
Clove Syzygium aromaticum buds 2310 brown
Cranberry Vaccinium macrocarpon fruit 2010 red
Green tea Camellia sinensis leaf 2215 light yellow
Honeybush Cyclopia genistoides leaf 1230 brown
Jamaica sorrel Hibiscus sabdariffa flower 3440 claret
Mountain ironwort Sideritis montana leaf 1600 ocher
Rosemary Rosmarinus officinalis leaf 3834 light yellow
White bean Phaseolus vulgaris pod 1730 russet
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ditions. Six plants, namely Cinnamomum zeylanicum, Camellia sinensis, Ribes 
nigrum, Laurus nobilis, Vaccinium macrocarpon, Syzygium aromaticum, revealed 
remarkable bioactivity. Other 5, namely Sideritis montana, Hibiscus sabdariffa, 
Cyclopia genistoides, Rosmarinus officinalis and Phaseolus vulgaris, plants dis-
played moderate or low α-amylase inhibitory potential.
Fig. 3. Kinetic curves of HSA catalysed CNP-G3 production from CNP-G7 hydrolysis in the presence of 
various plant extracts
Table 2
HSA inhibition effect of plant extracts
Inhibitor IC50 (µg/ml)
Relative inhibition 
(IC50/IC50 of acarbose)
Acarbose (control) 0.006 ± 0.0015 1
Cinnamomum zeylanicum 0.017 ± 0.002 2.8
Camellia sinensis 0.22 ± 0.08 36
Ribes nigrum 15 ± 3 2500
Laurus nobilis 25 ± 12 4166
Syzygium aromaticum 34 ± 5 5666
Vaccinium macrocarpon 41 ± 11 6833
IC50 values of plant extracts and acarbose, as positive control, measured on CNP-G7 substrate.
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HSA activity was measured at constant enzyme and substrate concentration using 
different dilutions of the selected six extracts. Inhibition potency, the concentration of 
inhibitor that decrease enzyme activity to the half (IC50), was determined and sum-
marised in Table 2.
DISCUSSION
During the past 25 years HPLC became undoubtedly the most important analytical 
method for identification and quantification of compounds, so it is available in almost 
all analytical lab. In parallel, the use of HPLC techniques in the study of enzymatic 
reactions has grown significantly. HPLC will be the method of choice for activity 
measurement if the components must be separated before quantitation, and detection 
of products is possible [20]. CNP-G7 hydrolysis by HSA met both criteria, since 
substrate and three released reducing end products were similar compounds (maltoo-
ligomers) and all contained chromophore group. The main product (CNP-G3) was 
quantified based on area data and reaction rates were calculated from linear part of 
kinetic curves.
Hot water extraction is similar to the normal application of these herbs as infusion 
or spices, which makes it more accessible and natural. Components of these extracts 
may achieve synergistic effects, therefore components were not prepared and exam-
ined separately.
The six plants selected showed great inhibitory effect on HSA, although the degree 
of inhibition is less than that measured for acarbose as a positive control. Two of 
them, cinnamon and green tea, were outstanding inhibitors with the low microgram/
ml IC50 value in accordance with the earlier published literary observations. Our 
results also suggest that these two plants may have positive effect on managing the 
postprandial hyperglycemia via the control of the digestive enzymes. IC50 values of 
different cinnamons were published between 1.23–4 mg/ml by Adisakwattana et 
al. [2], who examined the effect of aqueous cinnamon extract on porcine pancreatic 
α-amylase (PPA) catalysed starch hydrolysis reaction. These IC50 values were 
approximately twenty times higher than the value for acarbose (0.098 mg/ml), meas-
ured by the same method. Better results were published recently for hydro-alcoholic 
extract of cinnamon by Beejmohun et al. [3], where IC50 of 25 and 18 μg/ml was 
measured for cinnamon extract and acarbose, respectively. Their results of both in 
vitro PPA enzymatic assay with starch and in vivo starch tolerance test in rats demon-
strated the effectiveness of cinnamon components on diabetes [3]. 
Green tea, a popular drink, is rich in polyphenols and has beneficial effects in the 
treatment of diabetes mellitus because of the strong inhibitory effect on α-amylase 
and α-glucosidase [7, 17]. Published IC50 of 4.0 mg/ml value on PPA indicates only 
low inhibition, although acarbose was found also a week inhibitor of PPA (IC50 = 2.7 
mg/ml) [7]. Similar IC50 (2.07 mg/ml) was published for green tea on human pancre-
atic α-amylase (HPA) recently, using starch as substrate and released glucose deter-
mination by hexokinase kit as amylase activity measurement method [17]. Green tea 
α-Amylase inhibition by plant extracts 135
Acta Biologica Hungarica 68, 2017
extract showed lower inhibition efficiency than acarbose or cinnamon extract but it 
still can be classified as a promising inhibitor.
We measured similar inhibition potency (IC50 range between 10–50 μg/ml) for 
extracts of blackcurrant, bay, clove leaves and cranberry fruit. Polyphenol rich extract 
of berry fruits are known as amylase inhibitors [16, 19], but leaves of blackcurrant 
were not examined earlier. Extract of bay leaves in human and animal pilot studies 
decreased postprandial hyperglycemia, but α-amylase inhibition was not studied, so 
far [12]. Components, extracted by organic solvents from clove, inhibited PPA dose-
dependent manner. IC50 of 497.27 and 553.77 μg/ml was determined for aceton and 
ethylacetate extracts, respectively, using starch as substrate [1]. In an other study IC50 
of 37.1 and 36.2 μg/ml were measured for methanolic extracts of cinnamon and 
clove, similar to value 34.5 μg/ml of acarbose [21]. Our results verified the inhibition, 
the difference of IC50 values can be explained by the different methods of measure-
ment. Unfortunately, the previous results found in the literature are difficult to com-
pare with each other because different enzymes, substrates, activity measurement and 
extraction methods were used. 
Our results suggest that using cinnamon bark as a spice can potentially be useful 
to decrease glucose release from starch containing foods, since inhibition effect of 
components extractable with water from 1.2 g of cinnamon powder should be similar 
as effect of 150 mg (daily dose) acarbose. Calculation was made based on IC50 values 
of acarbose and cinnamon extract and extraction yield of cinnamon. The other five 
plants can be taken into consideration as a source of inhibitor compounds, and the 
plant extracts may be useful as a component of dietary supplements for weight loss 
or antidiabetic therapy. 
Our results confirm the applicability of our HPLC-based kinetic method as a 
highly accurate and reliable way of determination of herbal extracts inhibitory activ-
ity on α-amylase.
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